Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Author(s) -
KangYin Chen,
SeungWoon Rha,
Yong-Jian Li,
Kanhaiya L. Poddar,
Zhe Jin,
Yoshiyasu Minami,
Lin Wang,
Eung Ju Kim,
Chang Gyu Park,
Hong Seog Seo,
Dong Joo Oh,
Myung Ho Jeong,
Young Keun Ahn,
Taek Jong Hong,
Young Jo Kim,
SeungHo Hur,
In Whan Seong,
Jei Keon Chae,
MyeongChan Cho,
Jang Ho Bae,
Donghoon Choi,
Yangsoo Jang,
In Ho Chae,
Chong Jin Kim,
Junghan Yoon,
Wook Sung Chung,
Ki Bae Seung,
SeungJung Park
Publication year - 2009
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.108.822791
Subject(s) - medicine , percutaneous coronary intervention , cardiology , myocardial infarction , st segment , clopidogrel , elevation (ballistics) , geometry , mathematics
Whether triple antiplatelet therapy is superior or similar to dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention in the era of drug-eluting stents remains unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom